Rodney Glenn Mcdonald

Array ( [id] => 11977579 [patent_doc_number] => 20170281732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'METHODS OF TREATING MILD BRAIN INJURY' [patent_app_type] => utility [patent_app_number] => 15/505067 [patent_app_country] => US [patent_app_date] => 2015-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80506 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16369089 [patent_doc_number] => 10800830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-13 [patent_title] => High affinity PD-1 agents and methods of use [patent_app_type] => utility [patent_app_number] => 15/502439 [patent_app_country] => US [patent_app_date] => 2015-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 52 [patent_no_of_words] => 40891 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13154025 [patent_doc_number] => 10093725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Anti-NGF antibodies and their use [patent_app_type] => utility [patent_app_number] => 14/799182 [patent_app_country] => US [patent_app_date] => 2015-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 128 [patent_no_of_words] => 53124 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14799182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656181 [patent_doc_number] => 20160002324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'ANTI-NGF ANTIBODIES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 14/797719 [patent_app_country] => US [patent_app_date] => 2015-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 57935 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14797719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11699106 [patent_doc_number] => 09689010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Microbial-derived chondroitin sulfate' [patent_app_type] => utility [patent_app_number] => 14/793947 [patent_app_country] => US [patent_app_date] => 2015-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7210 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16591720 [patent_doc_number] => 10900976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-26 [patent_title] => Process for diagnosis of neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 15/320654 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 11986 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 297 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16493547 [patent_doc_number] => 10859581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => Methods and kits for detecting brain injury [patent_app_type] => utility [patent_app_number] => 15/319436 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 21023 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11567444 [patent_doc_number] => 20170106088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'MAGNETIC DIRECTED ALIGNMENT OF STEM CELL SCAFFOLDS FOR REGENERATION' [patent_app_type] => utility [patent_app_number] => 15/315247 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11521 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11627297 [patent_doc_number] => 20170137486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'PEPTIDE YY (PYY) ANALOGUES' [patent_app_type] => utility [patent_app_number] => 15/308751 [patent_app_country] => US [patent_app_date] => 2015-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16385 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12405126 [patent_doc_number] => 09968637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Dopaminergic neurons differentiated from pluripotent stem cells and uses thereof [patent_app_type] => utility [patent_app_number] => 14/718683 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12974 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430259 [patent_doc_number] => 20150315271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/704853 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 22102 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14456275 [patent_doc_number] => 10324094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Methods and compositions for detecting misfolded proteins [patent_app_type] => utility [patent_app_number] => 14/683908 [patent_app_country] => US [patent_app_date] => 2015-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 32358 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14683908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15512795 [patent_doc_number] => 10562973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein [patent_app_type] => utility [patent_app_number] => 15/129676 [patent_app_country] => US [patent_app_date] => 2015-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27063 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15129676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10714170 [patent_doc_number] => 20160060317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE' [patent_app_type] => utility [patent_app_number] => 14/681414 [patent_app_country] => US [patent_app_date] => 2015-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13189 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11704614 [patent_doc_number] => 20170173113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'METHODS OF DELIVERING HEPARIN BINDING EPIDERMAL GROWTH FACTOR USING STEM CELL GENERATED EXOSOMES' [patent_app_type] => utility [patent_app_number] => 15/123892 [patent_app_country] => US [patent_app_date] => 2015-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19835 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467098 [patent_doc_number] => 20150352113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'TREATMENT OF ASTROCYTES-TUMOR CELLS INHIBITORS OF ENDOTHELIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/640662 [patent_app_country] => US [patent_app_date] => 2015-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11150 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14640662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10339157 [patent_doc_number] => 20150224163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'TREATMENT OF NOISE INDUCED HEARING LOSS' [patent_app_type] => utility [patent_app_number] => 14/621978 [patent_app_country] => US [patent_app_date] => 2015-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7073 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14621978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11381577 [patent_doc_number] => 20170007633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'TREATMENT OF NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BY INHIBITION OF THE a2-Na/K ATPase/a-ADDUCIN COMPLEX' [patent_app_type] => utility [patent_app_number] => 15/117917 [patent_app_country] => US [patent_app_date] => 2015-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19043 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11348896 [patent_doc_number] => 20160367637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'METHODS OF TREATING MILD BRAIN INJURY' [patent_app_type] => utility [patent_app_number] => 15/114067 [patent_app_country] => US [patent_app_date] => 2015-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23239 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15666445 [patent_doc_number] => 10597440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-24 [patent_title] => Anti-transthyretin human antibody [patent_app_type] => utility [patent_app_number] => 15/114545 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 16043 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114545 [rel_patent_id] =>[rel_patent_doc_number] =>)